| Name | (1S,3S,4aR,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H- pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,4,4a,7,8,8a-octahydro-1-naph thalenyl (2S)-2-methylbutanoate |
|---|---|
| Synonyms |
Butanoic acid, 2-methyl-, 1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha (R*), 3-alpha, 4a-alpha, 7-beta, 8-beta (2S
Lovastatin Related Compound A (20 mg) (Dihydro-lovastatin) Lovastatin IMpurity E Lovastatin Impurity 5(Lovastatin Impurity E) Butanoic acid, 2-methyl-, (1S,3S,4,7S,8S,8aS)-1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S) LOVASTATIN IMPURITY E (DIHYDRO LOVASTATIN) (S)-2-Methylbutyric acid [(1S)-1,2,3,4,4a,7,8,8aα-octahydro-3β,7α-dimethyl-8α-[2-[[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran]-2-yl]ethyl]naphthalen]-1β-yl ester (1S,3S,4,7S,8S,8-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H- pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,4,4a,7,8,8a-octahydro-1-naph thalenyl (2S)-2-methylbutanoate (2S)-2-Methylbutanoic Acid (1S,3S,4,7S,8S,8aS)-1,2,3,4,4a,7,8,8a-Octahydro- 3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (S)-(1S,3S,4,7S,8S,8aS)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl 2-methylbutanoate (Lovastatin Impurity) Lovastatin Related CoMpound A dihydro-lovastatin 4a,5-Dihydro Lovastatin (S)-(1S,3S,4,7S,8S,8aS)-8-(2-((2R,4R) |
| Density | 1.1g/cm3 |
|---|---|
| Boiling Point | 534.8ºC at 760 mmHg |
| Molecular Formula | C24H38O5 |
| Molecular Weight | 406.55600 |
| Flash Point | 174.5ºC |
| Exact Mass | 406.27200 |
| PSA | 72.83000 |
| LogP | 4.27540 |
| Index of Refraction | 1.52 |
| RIDADR | NONH for all modes of transport |
|---|
| Precursor 1 | |
|---|---|
| DownStream 0 | |